Target intelligence / Profile preview

Proline and glutamate rich with coiled coil domain protein 1 (PERCC1)

Target
PERCC1
Molecular classification
Transcriptional co-regulator, YAP/TAZ/FAM181 family, Other
01

Overview

**Proline and glutamate rich with coiled coil domain protein 1 (PERCC1)** is a transcriptional co-regulator and a newly recognized member of the YAP/TAZ/FAM181 family, containing conserved TEAD-interacting motifs[1]. It is expressed at very low levels in a limited range of tissues, with highest expression in enteroendocrine cells, especially **gastric G cells** and duodenal enteroendocrine cells. PERCC1 plays a critical developmental role in the gastrointestinal tract by promoting the generation and function of enteroendocrine cells required for normal digestive physiology[1][3][4]. Loss of function causes a congenital diarrheal syndrome in humans and mice, due to failure of specific populations of gut endocrine cells to develop, resulting in nutrient malabsorption and failure to thrive[2]. Its precise molecular mechanism involves interaction with TEAD transcription factors—similar to YAP and TAZ—but unlike these canonical targets, PERCC1 currently has no known established interaction with small-molecule drugs and is not a validated therapeutic target[1][2][3][4]. No evidence currently supports a role in adult disease or cancer, and it does not have known drug interactions, biomarker roles, or safety concerns relevant to pharmacology at this time. It is not conventionally considered a therapeutic target, but is of research interest for rare congenital diarrheal diseases[1][2][3][4].

Other names
PERCC1Protein PERCC1Proline and glutamate-rich protein with a coiled coil domainDIAR11ICRgs104protein LOC105371045
02

Biological functions

Regulation of intestinal functionPromotion of enteroendocrine cell development in the gastrointestinal tractLikely involved in gastric and intestinal development through TEAD-interaction as a co-activator
03

Disease associations

Congenital diarrheal disorders, especially in infants (linked to intractable congenital diarrhea and malabsorption)Other (no strong evidence for involvement in cancer, inflammation, or other systemic disease as of now)

Beyond the preview

Go deeper on Proline and glutamate rich with coiled coil domain protein 1 (PERCC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline and glutamate rich with coiled coil domain protein 1 (PERCC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call